Conception and reality: Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments
Introduction: Inflammatory bowel disease potentially elevates the risk of infections, independently from age, while the disease activity and medical treatment(s) can also increase the risks. Nevertheless, it is necessary to clarify these preconceptions as well during the COVID-19 pandemic. Methods:...
Main Authors: | Tamás Resál, Mária Matuz, Csilla Keresztes, Péter Bacsur, Kata Szántó, Anett Sánta, Mariann Rutka, Diána Kolarovszki-Erdei, Renata Bor, Anna Fábián, Zoltán Szepes, Pál Miheller, Patrícia Sarlós, Anita Zacháry, Klaudia Farkas, Tamás Molnár |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136222001139 |
Similar Items
-
Ustekinumab is associated with superior treatment persistence but not with higher remission rates vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study
by: Péter Bacsur, et al.
Published: (2022-12-01) -
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination
by: Tamás Resál, et al.
Published: (2023-06-01) -
Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
by: Kata Szántó, et al.
Published: (2018-01-01) -
Burnout among European IBD specialists: a survey supported by ECCO
by: Anett Dávid, et al.
Published: (2023-11-01) -
The complex relationship between viruses and inflammatory bowel disease – review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic
by: Klaudia Farkas, et al.
Published: (2021-04-01)